Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Patient-doctor ethnic differences thwart end-of-life conversations

  • Verbal therapy could block consolidation of fear memories in trauma victims

  • Nerve cells, blood vessels in eye 'talk' to prevent disease

  • Locusts provide insight into brain response to stimuli, senses

  • Finding the body clock's molecular reset button

  • Breakthrough in understanding Canavan disease

  • Your adolescent brain on alcohol: Changes last into adulthood

  • Hate to diet? It's how we're wired

  • Brain balances perception and action when caught in an illusion

  • A 'GPS' to navigate the brain's neuronal networks

  •